These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 23137712)

  • 1. Treatment of lung infection in patients with cystic fibrosis: current and future strategies.
    Döring G; Flume P; Heijerman H; Elborn JS;
    J Cyst Fibros; 2012 Dec; 11(6):461-79. PubMed ID: 23137712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P; Whitaker P; Peckham D
    Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
    Taccetti G; Campana S; Festini F; Mascherini M; Döring G
    Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.
    Høiby N
    BMC Med; 2011 Apr; 9():32. PubMed ID: 21463524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin.
    Ehsan Z; Clancy JP
    Future Microbiol; 2015; 10(12):1901-12. PubMed ID: 26573178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic treatment of CF lung disease: from bench to bedside.
    Bals R; Hubert D; Tümmler B
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S146-51. PubMed ID: 21658633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa and the airways disease of cystic fibrosis.
    Hata JS; Fick RB
    Clin Chest Med; 1988 Dec; 9(4):679-89. PubMed ID: 3148384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approach to the eradication of Pseudomonas aeruginosa in an infant with CF after outpatient treatment failure.
    Hayes D; Kanga JF; Anstead MI; Kuhn RJ
    Pediatr Pulmonol; 2008 May; 43(5):511-3. PubMed ID: 18383117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa.
    van Gennip M; Moser C; Christensen LD; Bjarnsholt T; Calum H; Jensen PØ; Christophersen L; Hougen HP; Ciofu O; Molin S; Givskov M; Høiby N
    J Antimicrob Chemother; 2009 Dec; 64(6):1241-50. PubMed ID: 19815632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spanish consensus on the prevention and treatment of Pseudomonas aeruginosa bronchial infections in cystic fibrosis patients.
    Cantón R; Máiz L; Escribano A; Olveira C; Oliver A; Asensio O; Gartner S; Roma E; Quintana-Gallego E; Salcedo A; Girón R; Barrio MI; Pastor MD; Prados C; Martínez-Martínez MT; Barberán J; Castón JJ; Martínez-Martínez L; Poveda JL; Vázquez C; de Gracia J; Solé A;
    Arch Bronconeumol; 2015 Mar; 51(3):140-50. PubMed ID: 25614377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis.
    Mayer-Hamblett N; Kloster M; Rosenfeld M; Gibson RL; Retsch-Bogart GZ; Emerson J; Thompson V; Ramsey BW
    Clin Infect Dis; 2015 Sep; 61(5):707-15. PubMed ID: 25972024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis.
    Lahiri T
    Clin Chest Med; 2007 Jun; 28(2):307-18. PubMed ID: 17467550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nocardia farcinica infection in a patient with cystic fibrosis].
    Beucher J; Belleguic C; Brinchault G; Deneuville E; Donnio PY; Roussey M
    Rev Mal Respir; 2010; 27(1):76-9. PubMed ID: 20146956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic use in cystic fibrosis.
    Eisenberg JD
    Curr Opin Pulm Med; 1996 Nov; 2(6):439-46. PubMed ID: 9363182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early antibiotic treatment for eradication of initial infection by Pseudomonas aeruginosa in patients with cystic fibrosis].
    Giugno H; Castaños C; Lubatti A; Pinheiro JL; Hernández C; González Pena H
    Arch Argent Pediatr; 2010 Apr; 108(2):141-7. PubMed ID: 20467710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Döring G
    Int J Med Microbiol; 2010 Dec; 300(8):573-7. PubMed ID: 20940108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Pseudomonas aeruginosa in the pathogenesis of lung disease in cystic fibrosis: more questions than answers.
    Kerem E
    Pediatr Pulmonol Suppl; 1997; 16():265-6. PubMed ID: 9443305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.